Scope
Reference
C352808
Description
Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025 Offer reference number: CM/TNS/24/5721 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5721/01 - Nilotinib and Ticagrelor Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months) Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Commercial tool
Establishes a framework
Total value (estimated)
- £29,042,000 excluding VAT
- £34,850,400 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 September 2025 to 31 January 2027
- Possible extension to 31 July 2029
- 3 years, 11 months
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UK - United Kingdom
Engagement
Engagement deadline
25 April 2025
Engagement process description
NHS England is pleased to invite suppliers to contact us in relation to the upcoming tender for NHS National Framework for Transition products commencing 1st September 2025 (Ticagrelor and Nilotinib ) Please contact katie.noonan@nhs.net for further information and/or to register your interest.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
30 April 2025
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
7-8 Wellington Place
Leeds
LS1 4AP
United Kingdom
Email: katie.noonan@nhs.net
Website: https://www.england.nhs.uk/
Region: UKE42 - Leeds
Organisation type: Public authority - central government